Beeline Medicine — Valuation, Funding & Investors

We're still building this profile — here is what Pulse has covered.

Latest Pulse

Jul 5, 2026Biotech VCs Are Betting Big on Single Clinical TrialsCelea Therapeutics' $180M round, Beeline Medicine's $126.3M raise and Flare Therapeutics' $85M financing show late-stage biotech investors concentrating capital into single, high-conviction trial bets rather than diversified platform plays.→

Coverage Timeline

newest first

Jul 5, 2026FUNDINGBiotech VCs Are Betting Big on Single Clinical Trials$391M+ combined across 3 single-trial bets→

All Coverage

FUNDING· Jul 5, 2026

Biotech VCs Are Betting Big on Single Clinical Trials

FUNDING$391M+ combined across 3 single-trial bets

Biotech VCs Are Betting Big on Single Clinical Trials

Celea Therapeutics' $180M round, Beeline Medicine's $126.3M raise and Flare Therapeutics' $85M financing show late-stage biotech investors concentrating capital into single, high-conviction trial bets rather than diversified platform plays.

Jul 5, 2026

Related Companies

Same sector

Attovia Therapeutics Apnimed Braveheart Bio Latigo Biotherapeutics Scribe Therapeutics